| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |